Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Patent
1990-12-19
1996-06-25
Feisee, Lila
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
5303871, 53038822, 4241331, 4241431, A61K 39395, C07K 1628
Patent
active
055301010
ABSTRACT:
Novel methods for producing, and compositions of, humanized immunoglobulins having one or more complementarity determining regions (CDR's) and possible additional amino acids from a donor immunoglobulin and a framework region from an accepting human immunoglobulin are provided. Each humanized immunoglobulin chain will usually comprise, in addition to the CDR's, amino acids from the donor immunoglobulin framework that are, e.g., capable of interacting with the CDR's to effect binding affinity, such as one or more amino acids which are immediately adjacent to a CDR in the donor immunoglobulin or those within about 3 .ANG. as predicted by molecular modeling. The heavy and light chains may each be designed by using any one or all of various position criteria. When combined into an intact antibody, the humanized immunoglobulins of the present invention will be substantially non-immunogenic in humans and retain substantially the same affinity as the donor immunoglobulin to the antigen, such as a protein or other compound containing an epitope.
REFERENCES:
patent: 4816397 (1989-03-01), Boss et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 4867973 (1989-09-01), Geers et al.
patent: 5225539 (1993-07-01), Winter
Vitteta et al., "Redesigning Nature's Poisons to Create Anti-Tumor Reagents, " Science 238:1098-1104 (1987).
Ellison et al., "The nucleotide sequence of a human immunoglobulin C(gamma).sub.1 gene", Nucleic Acids Res. 10:4071-(1982).
Hieter et al., "Cloned Human and Mouse Kappa Immunoglobulin Constatn and J Region Genes Conserve homology in Functional Segments", Cell 22:197-207 (1980).
Sharon et al., "Expression of a V.sub.H C.sub.K chimaeric protein in mouse myeloma cells", Nature 309:364-367 (1984).
Takeda et al., "Construction of chimaeric processed immunoglobulin genes containing mouse variable and human constant region sequences", Nature 314:452-454 (1985).
Tan et al., "A Human-Mouse Chimeric Immunoglobulin Gene with a Human Variable Region is Expressed in Mouse Myeloma Cells", J. Immunol. 135:3564-3567 (1985).
Morrison et al., "Chimeric human antibody molecules: Mouse antigen-binding domains with human constant region domains," Proc. Natl. Acad. Sci. 81:6851-6859 (1984).
Boulianne et al., "Production of functional chimeric mouse/human antibody, " Nature 312:643-646 (1984).
Neuberger et al., "A hapten-specific chimeric IgE antibody with human physiological effector function," Nature 314:268-270 (1985).
Morrison, S. L., "Transfectomas Provide Novel Chimeric Antibodies," Science 229:1202-1207 (1985).
Sahagan et al., "A Genetically Engineered Murine/Human Chimeric Antibody Retains Specificity for Human Tumor-Associated Antigen", J. Immunol. 137:1066-1074 (1986).
Liu et al., "Expression of mouse::human immunoglobulin heavy-chain cDNA in lymphoid cells", Gene 54:33-40 (1987).
Better et al., "Escherichia coli Secretion of an Active Chimeric Antibody Fragment", Science 240:1041-1043 (1988).
Waldmann, T. A., "The Structure, Function, and Expression of Interleukin-2 Receptors on Normal and Malignant Lymphocytes," Science 232:727-732 (1986).
Leonard et al., "The human receptor for T-cell growth factor," J. Biol. Chem. 260:1872-1880 (1985).
Farrar, J., "The biochemistry, biology, and role of interleukin-2 in the induction of cytotoxic T cell and antibody-forming B cell receptors," Immunol. Rev. 63:129-166 (1982).
Greene et al., "Growth of Human T Lymphocytes: An Analysis of Interleukin 2 and Its Cellular receptor", in Progress in Hematology XIV, E. Brown ed., Grune and Statton, New York (1986) pp. 283-301.
Verhoyen et al., "Reshaping Human Antibodies: Grafting an Antilysozyme Activity", Science 239:1534-1536 (1988).
Jones et al., "Replacing the complementarity-determining regions in a human antibody with those from a mouse", Nature 321:522-525 (1986).
Hale et al., "Remission Induction in Non-Hodgkin Lymphoma with Reshaped Human Monoclonal Antibody CAMPATH-1H", Lancet Dec. 17, 1988, pp. 1394-1399.
Chothia, C. and A. M. Lesk, "Canonical Structures for the Hypervariable Regions of Immunoglobulins", J. Mol. Biol. 196:901-917 (1987).
Reichmann et al., "Reshaping human antibodies for therapy", Nature 332:323-327 (1988).
Bird et al., "Single-chain Antigen-Binding Proteins", Science 242:423-426 (1988).
Huston et al., "Protein engineering of antibody binding sites: Recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli", Proc. Natl. Acad. Sci. U.S.A. 85:5879-5883 (1988). in Progress in Hematology XIV, E. Brown, ed., Grune and Statton, New York (1986) p. 283.
Kirkman et al. Journal of Expt. Med. vol. 162 Jul. 1985 358.
Uchiyama et al. Journal of Immunology vol. 126 No. 4 1981, 1393.
Queen Cary L.
Selick Harold E.
Feisee Lila
Protein Design Labs, Inc.
LandOfFree
Humanized immunoglobulins does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Humanized immunoglobulins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Humanized immunoglobulins will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2189838